Effect of Elliptical Training on Metabolic Homeostasis in Metabolic Syndrome
1 other identifier
interventional
60
1 country
1
Brief Summary
The growing prevalence of metabolic syndrome (MetS) in the worldwide is becoming a serious health problem and economic burden. MetS has become a crucial risk factor for the development of type 2 diabetes mellitus (T2DM) and cardiovascular diseases (CVD). The rising rates of CVD and diabetes, which are the two leading causes of death. To prevent the progression of MetS to diabetes and CVD, regular physical activity is required. Elliptical trainer device is a relatively new modality of exercise and is advertised to be superior to a treadmill because of the low joint impact and the more reasonable costs of an elliptical trainer compared to a treadmill. Additional quantitative research is needed to further evaluate the effectiveness of elliptical trainers and the physiological and perceptual responses to the machine.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Sep 2020
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 9, 2020
CompletedFirst Submitted
Initial submission to the registry
November 13, 2020
CompletedFirst Posted
Study publicly available on registry
November 19, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 15, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2021
CompletedNovember 19, 2020
November 1, 2020
8 months
November 13, 2020
November 13, 2020
Conditions
Outcome Measures
Primary Outcomes (2)
Triglycerides
Triglycerides is one of lipid profile indicators
It will be measured after 16 weeks of training
high density lipoprotein
high density lipoprotein is one of lipid profile indicators
It will be measured after 16 weeks of training
Secondary Outcomes (9)
Systolic blood pressure
It will be measured after 16 weeks of training
diastolic blood pressure
It will be measured after 16 weeks of training
Fasting blood glucose
It will be measured after 16 weeks of training
Insulin
It will be measured after 16 weeks of training
The HOMA-IR (Homeostatic Model Assessment for Insulin Resistance
It will be measured after 16 weeks of training
- +4 more secondary outcomes
Study Arms (2)
group A
EXPERIMENTALpatients (n=30) in this group will receive 16 weeks of elliptical training on elliptical trainer, 3 times per week. the training will start with 5 minutes warming up at 50 % of maximal heart rate (MHR), 20-minute continuous ET at 70% of MHR, 12 minutes (4×3) intervals at 90% of MHR with a 3-minute active recovery at 70% of MHR between intervals, and finally 5-minute cool-down period at 50% of MHR
Group B (control group)
OTHERpatients (n=30) in this group will receive general advises on maintaining physical activities
Interventions
This group (n=30) will receive aerobic training on an elliptical trainer for 16 weeks (3 sessions per week). The session will start with 5 minutes warming up at 50 % of maximal heart rate (MHR), 20-minute continuous ET at 70% of MHR, 12 minutes (4×3) intervals at 90% of MHR with a 3-minute active recovery at 70% of MHR between intervals, and finally 5-minute cool-down period at 50% of MHR
this group will receive general advises on maintaining physical activities for 16 weeks without any additional supervised training
Eligibility Criteria
You may qualify if:
- The MeTS subjects who will have three or more of the following criteria: 1) waist circumference more than 102 cm, triglycerides more than 150 mg/dL, 3) blood pressure (BP) more than 130/85 mmHg, 4) high-density lipoprotein (HDL) less than 40 mg/dL, .
You may not qualify if:
- Renal, pulmonary, cardiac, vascular, respiratory, hepatic, autoimmune disorders.
- Smoker, addictive, cancer, and alcoholic patients.
- Lower limb arthritis or any orthopaedic problem will hinder the training.
- Participation in any type of sport training in the previous 6 months.
- Pregnant or lactating women.
- Patients with thyroid gland dysfunction.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Cairo Universitylead
Study Sites (1)
Faculty of Physical Therapy Cairo University
Giza, Dokki, Egypt
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Ali Ismail, lecturer
Cairo University
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- lecturer of Physical Therapy for Cardiovascular / Respiratory Disorder and Geriatrics, Faculty of Physical Therapy, Cairo University
Study Record Dates
First Submitted
November 13, 2020
First Posted
November 19, 2020
Study Start
September 9, 2020
Primary Completion
May 15, 2021
Study Completion
June 1, 2021
Last Updated
November 19, 2020
Record last verified: 2020-11